Hear what our previous attendees have to say about the NASH Summit
"This was a very informative conference that provided a great opportunity to network with top thought leaders and researchers in NASH."
"I found the conference very interesting. It was well organized and I like that it was small because it fostered a lot of discussion. The networking periods were extremely helpful and the speed networking was the highlight of the conference. I would love to have done a second round to meet the rest of the people and hear more about their work"
"Very targeted meeting filled with KOLs and industry leaders in this exciting field. Meeting organized and run better than any other conference I have attended."
"Well organized conference that brought the leading researchers and sponsors together to discuss topics highly relevant to the field. Well done."
"Extremely well organized. Perfect size with focus that enabled maximal interaction. Loved the speed dating concept"
"Great opportunity where I made over 10 key contacts that would not have been made otherwise. Progressed one key collaboration already!"
"Good representation of pharma, biotech, CRO and regulatory colleagues, which lead to stimulating conversations and presentations on: pathophysiology of NASH, potential targets, challenges involved in NASH clinical studies and developing regulatory and payer perspectives."
"This was my first NASH meeting and proved to be a very valuable experience, bringing me up to speed on what is happening in the field and areas of unmet need. It was also great for networking."
"The content of the conference was appropriately current, multidisciplinary, and relevant. Also I was struck with how everything ran like a well oiled machine. Never a glitch. This does not happen by accident. My hats off to HansonWade!"
"NASH summit was very well organized and well executed event. I learnt a lot about NASH within last 3 days. I am really looking forward to this next year in 2020."
"Excellent conference. Excellent speakers. I hope to attend again next year."
"Very informative, well-balanced review of the latest NASH research progress in relevant drug candidates and diagnotics. Was very pleased with the highly-interactive Summit organization."